SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Charles Salski who wrote (779)5/19/1998 10:49:00 PM
From: SOROS  Read Replies (1) of 1185
 
I urge anyone that holds more than 50,000 shares or more than 20% of your portfolio in Nortran to call the company. If you are skilled at listening, you can detect bull on the other end. You can sense when someone doesn't believe what they are telling you. I feel that Nortran is very positive and confident in their medicine and very upbeat and excited about the backing and chance they have with LaRoche. The market continues to defy my logic, but then it will come around. Usually when it languishes like this one has for too long, the second rise is very fast back. I'll enjoy that for the next 2 years -- quick rise to competitive value with other companies of equal opportunity and strength, and then steady growth.

I remain,

SOROS

ps Did you join us today, Mr. Forthright?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News